Biotech and Pharma Market Update: Q3 2025 in Review
Oct 23, 2025 01:15PM PST
The third quarter was a pivotal period for both biotech and pharma, with regulatory shifts, AI in R&D and major deals driving a resurgence in the sectors.
Life Science Investing: World
Whether it is genetics, medical devices, or beyond, get the comprehensive coverage you need to navigate the international life science markets confidently.
Latest Articles
Robotics Stocks: 10 AI, Medical and Industrial Leaders in 2025
Robotics InvestingSep 15, 2025 01:30PM PST
Why Does the US Federal Reserve Raise and Lower Interest Rates?
Gold InvestingSep 8, 2025 08:55AM PST
More Articles
Company Profiles
IVX:AU
Invion Limited
Revolutionizing Photodynamic Therapy (PDT) for cancer and infectious diseases
CDX:AU
Cardiex Limited
Biomarker technologies and digital solutions to address the world’s largest health disorders.
CEO Interviews
More CEO Interviews
life science News
Funded Collaboration Agreement with Protect Animal Health
Pharmaceutical InvestingOct 20, 2025 04:30PM PST
Canadian Investment Regulatory Organization Trade Resumption - CRDL
Biotech InvestingOct 20, 2025 02:56AM PST
Repayment of Lind Facility with Successful Capital Raise
Pharmaceutical InvestingOct 9, 2025 04:32PM PST
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock
SmartNewsOct 8, 2025 04:13PM PST
Seegnal Inc. Announces Extension of Maccabi Health Services Contract
Pharmaceutical InvestingSep 8, 2025 12:32PM PST
Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway
SmartNewsSep 8, 2025 12:01AM PST
Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results
Pharmaceutical InvestingSep 3, 2025 02:00AM PST
Editors' Picks
More Editors' Picks
